NSE Expands Derivatives Market: F&O Contracts on Piramal Pharma, Fortis Healthcare & UNO Minda from May 30

Image Source: ET Now

The National Stock Exchange of India (NSE) is set to introduce new futures and options (F&O) contracts on three additional securities—Piramal Pharma, Fortis Healthcare, and UNO Minda—starting May 30, 2025. This move aims to enhance market liquidity and provide investors with diversified trading opportunities.

Key Highlights

New F&O Contracts: NSE will launch derivatives trading on Piramal Pharma, Fortis Healthcare, and UNO Minda, expanding its offerings.
SEBI Approval: The contracts have received regulatory clearance from the Securities and Exchange Board of India (SEBI), ensuring compliance with stock selection criteria.
Market Lot & Strike Price: NSE will issue a separate circular on May 29 detailing the market lot and strike price scheme for the new contracts.
Trading System Update: Members are advised to upload updated contract files in their trading applications before the May 30 launch.
Options Expiry Changes: NSE had earlier deferred its plan to shift F&O expiry days for key indices, following SEBI’s consultation paper recommending Tuesday or Thursday expiries.
Investor Impact: The introduction of these contracts is expected to boost trading volumes, offering hedging and speculative opportunities for market participants.